REQUEST A DEMO
Total
USD $0.00
Search more companies

Pt Ciubros Farma (Indonesia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Pt Ciubros Farma Profile Updated: November 14, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Pt Ciubros Farma is an enterprise in Indonesia, with the main office in Semarang. The enterprise currently operates in the Pharmaceutical Preparation Manufacturing sector. The company was established on May 04, 1974. The latest financial highlights indicate a net sales revenue increase of 13.77% in 2024. There was a total growth of 14.48% in Pt Ciubros Farma’s total assets over the same period.

Headquarters
Kota Semarang Mangkang Kulon Tugu Jawa Tengah
Semarang; Central Java; Postal Code: 50155

Contact Details: Purchase the Pt Ciubros Farma report to view the information.

Basic Information
Registered Capital:
Purchase the Pt Ciubros Farma report to view the information.
Financial Auditors:
Purchase the Pt Ciubros Farma report to view the information.
Incorporation Date:
May 04, 1974
Key Executives
Purchase this report to view the information.
President Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Commissioner
Purchase this report to view the information.
Commissioner
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Pt Ciubros Farma report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IDR. Absolute financial data is included in the purchased report.
Net sales revenue
13.77%
Total Operating Revenue
13.77%
Total Assets
14.48%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?